ImpurityTrastuzumab Impurity 1Cat. No. P-T180-002CAS 34321-81-8Family · Pharmaceutical analytical standards
Trastuzumab
A humanised monoclonal antibody that blocks the HER2 receptor, used in HER2-positive breast and stomach cancers; approved in the United States in 1998 and in Europe in 2000, it has been included in the WHO List of Essential Medicines. This family brings together other impurities.
Did you know?The story of its development, linked to the work of oncologist Dennis Slamon at the University of California, Los Angeles, became a 2008 television film, Living Proof.
ImpurityTrastuzumab Impurity 1Cat. No. P-T180-002CAS 34321-81-8
ImpurityFmoc-Val-Cit-PAB-OHCat. No. P-T180-003CAS 159858-22-7
ImpurityFmoc-val-osuCat. No. P-T180-004CAS 130878-68-1No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.